BLOOMBERG LAW – Pfizer Inc. failed to warn patients that its injectable contraceptive drug Depo-Provera can increase the risk of developing brain tumors, a new lawsuit alleged.
“For several decades the manufacturers and sellers of Depo-Provera and its authorized generic and generic analogues” had a responsibility to investigate whether the medication could contribute to the growth of brain tumors, according to the complaint filed Monday in the US District Court for the Central District of California.
Plaintiff Taylor Devorak alleged that researchers have found Depo-Provera and similar progesterone medications have been linked to a greater incidence of brain tumors called intracranial meningioma.
She’s seeking damages on her failure-to-warn, defective design, negligence, misrepresentation, and breach of warranty claims against the pharmaceutical giant.
Devorak’s complaint comes in the wake of a handful of substantially similar lawsuits …
READ MORE
Depo-Provera (contraceptive injection)
Depo-Provera is a well-known brand name for medroxyprogesterone acetate, a contraceptive injection that contains the hormone progestin.
Depo-Provera is given as an injection every three months. Depo-Provera typically suppresses ovulation, keeping your ovaries from releasing an egg.
It also thickens cervical mucus to keep sperm from reaching the egg.
